Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?
Digoxin marketing requirements
Manufacturers of oral digoxin must submit an NDA or ANDA to continue to market their products, FDA says in Nov. 24 proposed rule. The rule revokes premarket approval of digoxin products under batch certification and says that generic versions of digoxin must reference Glaxo Wellcome's Lanoxin. Bertek and Amide recently sued FDA to remove Jerome Stevens/Duramed's digoxin from the market because it does not have an approved application (1"The Pink Sheet" Oct. 16, p. 7)
More from Archive
• By
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
• By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
• By
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
• By
The findings are consistent with some other research and likely are due to obesity patients becoming more connected to needed health care services.
• By
Chiesi’s orphan drug Raxone has secured an English funding recommendation for the treatment of Leber's hereditary optic neuropathy, a decade after the orphan drug was approved for marketing. Chiesi told the Pink Sheet about its “long, and often challenging” road to reimbursement.
• By
Norucholic acid and leriglitazone, for treating primary sclerosing cholangitis and cerebral adrenoleukodystrophy, respectively, are among 12 new drugs that the European Medicines Agency has started to review for potential EU marketing approval.